Keytruda

An arrow incrementally going up stairs before pointing straight up Blue background

Pharma

Keytruda, Padcev keep winning streak in bladder cancer

The PD-1/ADC combo showed an overall survival benefit as a perioperative treatment in patients with cisplatin-eligible muscle-invasive bladder cancer.

Angus Liu Dec 17, 2025 9:53am

Merck's Keytruda SC launch in Germany faces legal hurdle

Dec 5, 2025 9:30am

Merck partner Kelun touts ph. 3 win for ADC in first-line NSCLC

Nov 24, 2025 10:56am

Padcev, Keytruda combo scores game-changing FDA nod

Nov 21, 2025 1:22pm

Fierce Biotech

Pfizer lays out its PD-1xVEGF bispecific research strategy

Nov 11, 2025 11:43am

Merck's pneumococcal shot Capvaxive off to 'very strong start'

Oct 30, 2025 11:12am